Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Tane Hunter"'
Autor:
Paul Yeh, Tane Hunter, Devbarna Sinha, Sarah Ftouni, Elise Wallach, Damian Jiang, Yih-Chih Chan, Stephen Q. Wong, Maria Joao Silva, Ravikiran Vedururu, Kenneth Doig, Enid Lam, Gisela Mir Arnau, Timothy Semple, Meaghan Wall, Andjelija Zivanovic, Rishu Agarwal, Pasquale Petrone, Kate Jones, David Westerman, Piers Blombery, John F. Seymour, Anthony T. Papenfuss, Mark A. Dawson, Constantine S. Tam, Sarah-Jane Dawson
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-7 (2017)
Disease monitoring of chronic lymphocytic leukaemia (CLL) is a challenge. Here, the authors show that serial ctDNA analysis in 32 CLL patients allows monitoring of clonal dynamics over time, and identifies the emergence of genomic changes associated
Externí odkaz:
https://doaj.org/article/a5d0115fb7e149b29d91aa033cf28281
Autor:
Kathleen C. Rayeroux, Jason Li, Omer Gilan, Sarah Ftouni, Daniel H.D. Gray, Kathy Knezevic, Constantine S. Tam, Sarah-Jane Dawson, Meaghan Wall, Adrian Zordan, Mark A. Dawson, Charis E Teh, Rachel Thijssen, Tane Hunter, Stephen Q. Wong, Yih-Chih Chan, Mary Ann Anderson, David C.S. Huang, Christiane Pott, Charles C. Bell, Dane Vassiliadis, Piers Blombery, Enid Y.N. Lam, John F. Seymour, Rishu Agarwal, Andrew W. Roberts, Paul Yeh
Publikováno v:
Nature Medicine. 25:119-129
Ibrutinib plus venetoclax is a highly effective combination in mantle cell lymphoma. However, strategies to enable the evaluation of therapeutic response are required. Our prospective analyses of patients within the AIM study revealed genomic profile
Autor:
Ravikiran Vedururu, Mark A. Dawson, Ken Doig, Sarah-Jane Dawson, Stephen Q. Wong, Paul Yeh, Michael Dickinson, Sarah Ftouni, Piers Blombery, Devbarna Sinha, David Westerman, Rishu Agarwal, Tane Hunter, Chun Yew Fong
Publikováno v:
Blood. 129:1685-1690
The diagnosis and monitoring of myelodysplastic syndromes (MDSs) are highly reliant on bone marrow morphology, which is associated with substantial interobserver variability. Although azacitidine is the mainstay of treatment in MDS, only half of all
Autor:
Pasquale Petrone, Andjelija Zivanovic, Sarah Ftouni, Devbarna Sinha, Constantine S. Tam, Maria Joao Silva, Tane Hunter, Gisela Mir Arnau, Paul Yeh, Rishu Agarwal, Ken Doig, Kate Jones, Enid Y.N. Lam, Ravikiran Vedururu, John F. Seymour, Timothy Semple, Mark A. Dawson, Damian Jiang, Stephen Q. Wong, Piers Blombery, Meaghan Wall, Sarah-Jane Dawson, Yih-Chih Chan, Anthony T. Papenfuss, Elise Wallach, David Westerman
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-7 (2017)
Nature Communications
Nature Communications
Several novel therapeutics are poised to change the natural history of chronic lymphocytic leukaemia (CLL) and the increasing use of these therapies has highlighted limitations of traditional disease monitoring methods. Here we demonstrate that circu
Autor:
Rishu, Agarwal, Yih-Chih, Chan, Constantine S, Tam, Tane, Hunter, Dane, Vassiliadis, Charis E, Teh, Rachel, Thijssen, Paul, Yeh, Stephen Q, Wong, Sarah, Ftouni, Enid Y N, Lam, Mary Ann, Anderson, Christiane, Pott, Omer, Gilan, Charles C, Bell, Kathy, Knezevic, Piers, Blombery, Kathleen, Rayeroux, Adrian, Zordan, Jason, Li, David C S, Huang, Meaghan, Wall, John F, Seymour, Daniel H D, Gray, Andrew W, Roberts, Mark A, Dawson, Sarah-Jane, Dawson
Publikováno v:
Nature medicine. 25(1)
Ibrutinib plus venetoclax is a highly effective combination in mantle cell lymphoma. However, strategies to enable the evaluation of therapeutic response are required. Our prospective analyses of patients within the AIM study revealed genomic profile
Publikováno v:
Clinical Cancer Research. 21:POSTER-CTRL
Women who carry a germline BRCA1 or BRCA2 mutation are at high risk of developing ovarian cancer in their lifetime. While risk can be reduced by prophylactic bilateral salpingo-oopherectomy (RRSBO), for those high-risk women who delay, or choose not